Camel2park: Створена сторінка: Of 3,283 patients with valid PRU measurements, 625 (19.0%) met the inclusion criterion of PRU >208 and were invited to participate in the randomized study. A to...

2017-07-14T10:11:33Z

Створена сторінка: Of 3,283 patients with valid PRU measurements, 625 (19.0%) met the inclusion criterion of PRU >208 and were invited to participate in the randomized study. A to...

Нова сторінка

Of 3,283 patients with valid PRU measurements, 625 (19.0%) met the inclusion criterion of PRU >208 and were invited to participate in the randomized study. A total of 202 patients declined participation in the study. We, thus, finally randomized 423 patients, 212 of whom were assigned to prasugrel and 211 to clopidogrel. [http://www.selleckchem.com/products/Metformin-hydrochloride(Glucophage).html click here] Within each group, 210 patients received at least 1 dose of the assigned study medication. There were no significant differences in any of the baseline, clinical, and procedural characteristics between the 2 treatment arms (Table 1). Baseline PRU was well matched between the 2 study groups (p = 0.805) (Table 1, Fig. 2). One hundred forty-seven patients discontinued the study prematurely after a median of 90 days (interquartile range: 44 to 132 days). This was mostly due to early termination of the study (n = 118); other reasons included early revocation of consent (n = 5) or unwillingness to continue with the study (n = 24). Finally, 136 patients assigned to prasugrel and 137 patients assigned to clopidogrel ultimately completed the study. In the prasugrel arm, we obtained a least 1 valid PRU measurement on study medication in 191 patients and a valid subsequent PRU measurement in 139 patients on the study drug. In the clopidogrel arm, the respective numbers were 197 and 144. At the first blinded [http://en.wikipedia.org/wiki/PSCD4 CYTH4] PRU measurement in patients on the study drug, which was performed after a median of [http://www.selleckchem.com/products/isrib-trans-isomer.html ISRIB in vivo] 90 days (interquartile range: 88 to 94 days), median PRU on prasugrel was significantly lower than that on clopidogrel (Fig. 2). Thus, we observed a substantial decrease in PRU in the prasugrel arm (p

Beneficial But also Attractive ISRIB Guidelines - Історія редагувань

Camel2park: Створена сторінка: Of 3,283 patients with valid PRU measurements, 625 (19.0%) met the inclusion criterion of PRU >208 and were invited to participate in the randomized study. A to...